• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

Medical News Interviews

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Audio Journal of Oncology in Advance – May 1st, 2007 – reporting from: American Association for Cancer Research 14-18 April, 2007 Los Angeles

0
  • by alexperjescuadmin
  • in ASCO · Oncology
  • — 2 May, 2007
Fritz Schröder
Fritz Schröder

Opportunistic Prostate Screening May Not Save Lives!

REFERENCE: AACR 2007, Los Angeles
FRITZ SCHRÖDER, Erasmus University, Rotterdam
Though elective screening appears to have reduced the number of patients who die from prostate cancer in the United States, this has yet to be proven. A large European study is currently seeking to settle the matter, and one of the investigators, Fritz Schröder took part in a debate at the AACR entitled: Opportunistic Screening for Prostate Cancer: The Up and Down Sides of PSA Testing. Peter Goodwin talked with him about the dilemmas involved with prostate screening.

Peter Scardino
Peter Scardino

Debate on PSA Screening

REFERENCE: AACR 2007, Los Angeles
PETER SCARDINO, Memorial Sloan-Kettering Cancer Center, New York
The benefits of prostate cancer screening programs were questioned in a debate at the AACR conference in Los Angeles. Because the link between early detection and mortality is not simple, treatment risks could mean there is still an argument for watchful waiting in many patients. Peter Goodwin talked with Peter Scardino about the problems clinicians are facing in the age of the PSA test.

To listen this episode please go to ASCO Audio Journal of Oncology in Advance Presentations.
Share

Tags: aacrASCOaudio journal of oncologyFritz Schröderpeter scardinoprostatepsa screning

You may also like...

  • Polygenic Risk Scores Could Help Predict Second Primary Breast Cancers—AUDIO JOURNAL OF ONCOLOGY Polygenic Risk Scores Could Help Predict Second Primary Breast Cancers—AUDIO JOURNAL OF ONCOLOGY 28 Mar, 2018
  • Abdenour Nabid Androgen Blockade: 18 As Good As 36 Months In Radiotherapy-Treated Prostate Cancer 16 Mar, 2013
  • Peter Campbell MD PhD, head of Cancer Genetics and Genomics at the Sanger Institute in Cambridge International Research and Consensus Needed to Interpret Breast Cancer Genomics Data 27 Mar, 2015
  • Neoadjuvant Trastuzumab: Marked Benefit in HER2-Positive Inflammatory Breast Cancer Neoadjuvant Trastuzumab: Marked Benefit in HER2-Positive Inflammatory Breast Cancer 16 Oct, 2007

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story Audio Journal of Global Health Issues: Drug Eluting Stents, PFO Closure: Indications Not Obvious
  • Next story Fewer Major Bleeding Events with Bivalirudin For Patients with Acute Coronary Syndromes: The ACUITY study
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Microbiome Diversity Key To Survival After…
    • CT Screening Cuts Lung Cancer Deaths 24 Per…
    • Ibrutinib: New Frontline Standard for Chronic…
    • Volume CT Lung Cancer Screening Cuts Cancer Deaths…
    • Genomic-led AML Clinical Decision Making Within Seven Days
  • Home
  • Oncology
  • ASCO
  • Audio Journal of Oncology in Advance – May 1st, 2007 – reporting from: American Association for Cancer Research 14-18 April, 2007 Los Angeles

© Copyright 2021 AudioMedica.com. Typegrid Theme by WPBandit.